The role of levamisole co-administration hepatitis B vaccine in immunization.
Phase 3
- Conditions
- eed for immunization against viral hepatitis.Persons with potential health hazards related to communicable diseases
- Registration Number
- IRCT2014110618915N2
- Lead Sponsor
- Mashad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 217
Inclusion Criteria
16 years old and older without a history of a chronic disease or previous hepatitis B vaccination.
Exclusion criteria: current smoking and/or addiction to any form of drug; body mass index above 30 kg/m2; previous history of hepatitis B vaccination or infection; positive testing for HBs Ag or HBs Ab; any current chronic and/or acute disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate to the hepatitis B vaccine when levamisole is co-administered. Timepoint: HBs Ab levels are measured one month after the final dose of the vaccine. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method